Medium-scale biology CDMO

Viral vectors for early-stage teams.

AAV, HSV, and lentiviral production for researchers and startups who need professional execution without enterprise overhead.

Fair pricing. Clear timelines. Decision-grade deliverables.

Why other CDMOs don't fit

  • Long queues that block iteration
  • High minimums for simple validation runs
  • No direct access to the scientists doing your work
  • Pricing built for enterprise, not early-stage

We remove these constraints so you can iterate fast and scale when ready.

The real cost of workarounds

Teams get blocked by access and timelines, not ideas.

Compromised experiments

  • Constructs trimmed to fit delivery limits
  • Noisy readouts from suboptimal delivery
  • Repeated runs because setup wasn't scalable

Downstream impact

  • Data you can't confidently act on
  • Longer timelines to prove feasibility
  • More spend before fundraising or scale

Who we serve

Teams between academia and enterprise who need professional execution without institutional access.

Independent researchers

Professional execution and documentation for serious projects.

Pre-Series A founders

Decision-grade data without enterprise overhead.

Small labs

Scale beyond benchtop without building facilities.

Services

Design support, production, and QC for your stage. See vector-specific details below.

Vector production

Small-batch runs with decision-grade QC.

Additional services

Shared-services execution for work you can't do in-house.

  • Construct and genome builds
  • Analytical and QC packages
  • Process development and scale-up

How we work

Simple scoping so you can get to a decision quickly.

1
Scope
Define the smallest deliverable that answers your question.
2
Execute
Clear checkpoints and updates you can share with stakeholders.
3
Deliver
Material and documentation ready for next steps.

Get in touch

Email us at info@braidingbio.com or fill out the form below.

We'll respond within 24 hours.

What to include

  • Construct length and key features
  • Promoter and regulatory elements
  • Target cell type and MOI range
  • QC needs (titer, purity, sterility)
  • Desired timeline